Overview
The goal of this activity is to provide pharmacists with an overview on the pharmacotherapy recommended for the management of benign prostatic hyperplasia (BPH), to enable them to engage in knowledgeable discussions with patients regarding therapy options.
Content:
Who should participate:
Pharmacists
NOTE :
Terms & Conditions:
■ Each participant will only have 1 attempt at answering the questions
■ Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
Please read thoroughly & understand the module before attempting the assessment questions.
The modules/articles are best viewed with :